Home  |  Contact

UniProtKB/Swiss-Prot Q9ULV1: Variant p.Met342Val

Frizzled-4
Gene: FZD4
Variant information

Variant position:  342
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:  LP/P [Disclaimer]
The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change:  From Methionine (M) to Valine (V) at position 342 (M342V, p.Met342Val).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:  Similar physico-chemical property. Both residues are medium size and hydrophobic.
The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:  1
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description:  In EVR1.
Any additional useful information about the variant.

Other resources:  
Links to websites of interest for the variant.



Sequence information

Variant position:  342
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:  537
The length of the canonical sequence.

Location on the sequence:   ILTLTWFLAAGLKWGHEAIE  M HSSYFHIAAWAIPAVKTIVI
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation: 
The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         ILTLTWFLAAGLKWGHEAIEMHSSYFHIAAWAIPAVKTIVI

Mouse                         ILTLTWFLAAGLKWGHEAIEMHSSYFHIAAWAIPAVKTIVI

Rat                           ILTLTWFLAAGLKWGHEAIEMHSSYFHIAAWAIPAVKTIVI

Chicken                       ILTLTWFLAAGLKWGHEAIEMHSSYFHIAAWAIPAVKTIVI

Xenopus laevis                ILTLTWFLAAGLKWGHEAIEMHSSYFHIAAWAIPAVKTIVI

Sequence annotation in neighborhood:  
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.

TypePositionsDescription
Chain 37 – 537 Frizzled-4
Transmembrane 337 – 365 Helical; Name=4
Disulfide bond 302 – 377
Mutagenesis 341 – 341 E -> A. Reduced signaling activity in presence of NDP/norrin.


Literature citations

Novel mutation in FZD4 gene in a Japanese pedigree with familial exudative vitreoretinopathy.
Yoshida S.; Arita R.; Yoshida A.; Tada H.; Emori A.; Noda Y.; Nakao S.; Fujisawa K.; Ishibashi T.;
Am. J. Ophthalmol. 138:670-671(2004)
Cited for: VARIANT EVR1 VAL-342;

Complexity of the genotype-phenotype correlation in familial exudative vitreoretinopathy with mutations in the LRP5 and/or FZD4 genes.
Qin M.; Hayashi H.; Oshima K.; Tahira T.; Hayashi K.; Kondo H.;
Hum. Mutat. 26:104-112(2005)
Cited for: VARIANTS EVR1 TYR-69; VAL-105; CYS-335; VAL-342; GLN-417 AND ASP-488;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.